|
|
Volumn 19, Issue 12, 2001, Pages 519-523
|
|
Pharmacogenomics: Out of the lab and into the community
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DECISION MAKING;
METABOLISM;
TOXICITY;
INTERINDIVIDUAL DIFFERENCES;
DRUG DOSAGE;
CHLORPYRIFOS;
CYTOCHROME P450 2A6;
CYTOCHROME P450 2D6;
DIMPYLATE;
EPOXIDE HYDROLASE;
OXIDOREDUCTASE;
PARATHION;
REPETITIVE DNA;
SARIN;
SOMAN;
BIOTECHNOLOGY;
PHARMACEUTICAL INDUSTRY;
ALLELE;
CANCER RISK;
DECISION MAKING;
DISABILITY;
DNA SEQUENCE;
DOSE CALCULATION;
DRUG METABOLISM;
ENZYME DEFECT;
ETHNIC DIFFERENCE;
GENETIC SUSCEPTIBILITY;
GENOTYPE;
HAPLOTYPE;
HEALTH INSURANCE;
HUMAN;
MEDICAL ETHICS;
MEDICAL GENETICS;
MOLECULAR CLONING;
PHARMACOGENOMICS;
PHENOTYPE;
PRIORITY JOURNAL;
REVIEW;
SEQUENCE ANALYSIS;
SINGLE NUCLEOTIDE POLYMORPHISM;
TANDEM REPEAT;
BASE SEQUENCE;
DECISION MAKING;
DELIVERY OF HEALTH CARE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ETHICS;
GENOTYPE;
HUMANS;
INFORMATION SERVICES;
INSURANCE, HEALTH;
JURISPRUDENCE;
PHARMACOGENETICS;
PRIVACY;
RESIDENCE CHARACTERISTICS;
SOCIAL CHANGE;
|
|
EID: 0035575650
PISSN: 01677799
EISSN: None
Source Type: Journal
DOI: 10.1016/S0167-7799(01)01805-4 Document Type: Review |
|
Times cited : (33)
|
|
References (21)
|
